+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Apigenin - Global Strategic Business Report

  • PDF Icon

    Report

  • 185 Pages
  • May 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 6070104
The global market for Apigenin was estimated at US$276.2 Thousand in 2025 and is projected to reach US$332.5 Thousand by 2032, growing at a CAGR of 2.7% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Apigenin Market - Key Trends & Drivers Summarized

Why Is Apigenin Gaining Prominence Across Diverse Industries?

Apigenin, a naturally occurring flavonoid found in various plant sources such as chamomile, parsley, celery, and citrus fruits, is gaining widespread attention for its applications across pharmaceuticals, nutraceuticals, cosmetics, and functional food industries. As consumer preferences shift toward plant-derived bioactive compounds, apigenin is emerging as a highly sought-after ingredient due to its potential health-promoting properties and increasing scientific validation. The demand for botanical extracts in the pharmaceutical sector has surged, with apigenin being explored for its potential in oncology, cardiovascular health, and neuroprotection. Meanwhile, the functional food and nutraceutical industry has embraced apigenin as a key ingredient in dietary supplements aimed at promoting overall wellness and longevity. Additionally, the clean beauty movement has further propelled its use in skincare and personal care formulations, where it is being integrated into anti-aging creams, serums, and UV-protection formulations. The expanding consumer awareness regarding natural and plant-based ingredients is reinforcing the prominence of apigenin, positioning it as a crucial component in holistic health and wellness solutions.

How Are Technological Innovations Enhancing Apigenin Extraction and Formulation?

The advancement of extraction technologies and formulation techniques has played a pivotal role in improving the commercial viability of apigenin for industrial applications. Traditional solvent extraction methods are now being supplemented with more efficient approaches such as supercritical fluid extraction, ultrasound-assisted extraction (UAE), and enzymatic hydrolysis, which enhance yield, purity, and bioavailability. Furthermore, advancements in nanotechnology and encapsulation techniques, such as liposomal and polymeric nanoparticle delivery systems, have significantly improved the stability and absorption of apigenin in both pharmaceutical and cosmetic formulations. These innovations have made it possible to develop apigenin-based products with enhanced bioefficacy and controlled-release mechanisms, increasing its applicability across multiple sectors. Additionally, AI-driven formulation techniques are enabling manufacturers to optimize apigenin-based compounds for targeted therapeutic applications, reducing production costs and improving scalability. The integration of biotechnology, particularly microbial biosynthesis, is also paving the way for sustainable and consistent production of apigenin, reducing dependence on seasonal plant sources and improving supply chain resilience. As technological advancements continue to enhance extraction efficiency and formulation stability, apigenin is set to become a mainstream bioactive compound in the health and wellness industry.

What Market Trends Are Driving the Demand for Apigenin-Based Products?

Several key market trends are shaping the demand for apigenin-based products, particularly in the nutraceutical, pharmaceutical, and personal care industries. The increasing consumer inclination toward natural and organic ingredients has led to a surge in demand for plant-derived bioactives, positioning apigenin as a preferred alternative to synthetic compounds in dietary supplements and functional foods. The growing popularity of nootropics and cognitive-enhancing supplements has further fueled interest in apigenin, with research supporting its role in cognitive health and neuroprotection. Meanwhile, the skincare industry is witnessing a shift towards botanically sourced ingredients, driving the incorporation of apigenin into anti-aging, antioxidant-rich, and anti-inflammatory skincare formulations. The rise of personalized nutrition and precision medicine has also contributed to the expansion of the apigenin market, as scientific research continues to uncover its role in targeted health applications. Additionally, regulatory shifts promoting the use of naturally occurring flavonoids in functional foods and pharmaceuticals have facilitated market entry for apigenin-based products. The increasing penetration of e-commerce and direct-to-consumer (DTC) wellness brands has further accelerated the adoption of apigenin, making it more accessible to health-conscious consumers worldwide. These evolving trends indicate a sustained market trajectory, with apigenin poised for significant growth across multiple consumer-driven industries.

What Are the Key Growth Drivers Fueling the Apigenin Market Expansion?

The growth in the apigenin market is driven by several factors, including advancements in extraction and formulation technologies, increasing consumer demand for botanical-based supplements, and the expanding application scope in pharmaceuticals, nutraceuticals, and cosmetics. The rising investment in clinical research supporting apigenin’s therapeutic potential is encouraging pharmaceutical companies to explore new drug formulations incorporating this bioactive flavonoid. The functional food and beverage industry’s expansion, particularly in regions such as North America, Europe, and Asia-Pacific, is contributing to higher demand for apigenin-enriched products targeting immune support, cognitive function, and metabolic health. Additionally, the clean beauty movement and sustainability-driven innovations in skincare are further accelerating apigenin’s adoption in cosmetic formulations. The increasing regulatory approvals for flavonoid-based functional ingredients are facilitating global market growth, prompting companies to focus on compliance, safety, and efficacy to meet evolving consumer expectations. The rapid growth of digital health platforms and personalized wellness solutions is also shaping market trends, allowing consumers to access apigenin-based products tailored to their specific health needs. With ongoing innovations, expanding industry applications, and evolving consumer preferences, the apigenin market is set for continuous expansion, offering new opportunities for manufacturers and stakeholders across multiple sectors.

Report Scope

The report analyzes the Apigenin market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Type (0.95 Purity Level, 0.98 Purity Level, Other Types): Application (Pharma & Healthcare Application, Food Additives Application, Cosmetic & Skin Care Application, Other Applications).
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the 0.95 Purity Level Apigenin segment, which is expected to reach US$194.3 Thousand by 2032 with a CAGR of 3.0%. The 0.98 Purity Level Apigenin segment is also set to grow at 2.0% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $85.4 Thousand in 2025, and China, forecasted to grow at an impressive 5.1% CAGR to reach $74.4 Thousand by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Apigenin Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Apigenin Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Apigenin Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Anhui Sinotech Industrial, Cayman Chemical Company, Chengdu Chenlv Biological Technology, Codeage LLC, Enzo Life Sciences, Inc. and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Apigenin market report include:

  • Anhui Sinotech Industrial
  • Cayman Chemical Company
  • Chengdu Chenlv Biological Technology
  • Codeage LLC
  • Enzo Life Sciences, Inc.
  • Fuyang Bestop Import And Export Ltd.
  • Glentham Life Sciences Ltd.
  • HealthTech BioActives
  • Hello Bio Ltd.
  • INDOFINE Chemical Company, Inc.
  • Jinan Tantu Chemicals
  • Lanyor Biotech Co., Ltd.
  • Mianyang Di`ao Pharmaceutical Co., Ltd.
  • S. Nihar Exports
  • Selleck Chemicals
  • Shaanxi Pioneer Biotech Co., Ltd.
  • Sunriver Biotech
  • Wuhan Hengheda Pharm Co., Ltd.
  • Xi`an Arisun ChemPharm Co., Ltd.
  • Xi`an Bettering Biotech Co., Ltd.

Domain Expert Insights

This market report incorporates insights from domain experts across enterprise, industry, academia, and government sectors. These insights are consolidated from multilingual multimedia sources, including text, voice, and image-based content, to provide comprehensive market intelligence and strategic perspectives. As part of this research study, the publisher tracks and analyzes insights from 43 domain experts. Clients may request access to the network of experts monitored for this report, along with the online expert insights tracker.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind
  • Apigenin - Global Key Competitors Percentage Market Share in 2026 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2026 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Interest in Flavonoid-Based Natural Compounds Spurs Demand for Apigenin in Dietary Supplements
  • Growing Scientific Validation of Anti-Inflammatory and Antioxidant Benefits Strengthens Business Case for Apigenin
  • Expansion of Nutraceutical and Functional Food Sectors Accelerates Inclusion of Apigenin as a Bioactive Ingredient
  • Increased Consumer Focus on Natural Health Products Throws the Spotlight on Botanical Extracts Like Apigenin
  • Advancements in Extraction and Purification Technologies Drive Cost-Efficient and High-Purity Production
  • Rising Interest in Plant-Based Ingredients in Cosmetics and Personal Care Fuels Use of Apigenin in Skincare Formulations
  • Surge in Cancer Research and Preclinical Studies Expands Therapeutic Interest in Apigenins Cytoprotective Properties
  • Growth in Herbal Drug Development and TCM Integration Generates New Use-Cases for Apigenin
  • Regulatory Support for Natural Antioxidants in Food Preservation Drives Adoption in Clean Label Foods
  • Demand for Neuroprotective and Cognitive Health Supplements Accelerates Application of Apigenin in Brain Health
  • Expansion of Vegan and Plant-Based Nutrition Trends Creates Favorable Market Conditions
  • Increasing Inclusion of Apigenin in Sports and Performance Nutrition Formulations Sustains Growth
  • Collaboration Between Supplement Manufacturers and Botanical Research Institutions Enhances Product Innovation
  • Availability of Apigenin in Multiple Delivery Formats Broadens Consumer Appeal
  • Growing Demand for Immune-Boosting and Anti-Aging Products Strengthens Market for Bioflavonoid Compounds
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Apigenin Market Analysis of Annual Sales in US$ for Years 2020 through 2032
  • Table 2: World Recent Past, Current & Future Analysis for Apigenin by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • Table 3: World Historic Review for Apigenin by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 4: World 13-Year Perspective for Apigenin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
  • Table 5: World Recent Past, Current & Future Analysis for 0.95 Purity Level by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • Table 6: World Historic Review for 0.95 Purity Level by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 7: World 13-Year Perspective for 0.95 Purity Level by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for 0.98 Purity Level by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • Table 9: World Historic Review for 0.98 Purity Level by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 10: World 13-Year Perspective for 0.98 Purity Level by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 11: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • Table 12: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 13: World 13-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
  • Table 14: USA Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • Table 15: USA Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 16: USA 13-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2020, 2026 & 2032
CANADA
  • Table 17: Canada Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • Table 18: Canada Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 19: Canada 13-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2020, 2026 & 2032
JAPAN
  • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
  • Table 20: Japan Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • Table 21: Japan Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 22: Japan 13-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2020, 2026 & 2032
CHINA
  • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
  • Table 23: China Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • Table 24: China Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 25: China 13-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2020, 2026 & 2032
EUROPE
  • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
  • Table 26: Europe Recent Past, Current & Future Analysis for Apigenin by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • Table 27: Europe Historic Review for Apigenin by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 28: Europe 13-Year Perspective for Apigenin by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020, 2026 & 2032
  • Table 29: Europe Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • Table 30: Europe Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 31: Europe 13-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2020, 2026 & 2032
FRANCE
  • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
  • Table 32: France Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • Table 33: France Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 34: France 13-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2020, 2026 & 2032
GERMANY
  • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
  • Table 35: Germany Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • Table 36: Germany Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 37: Germany 13-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2020, 2026 & 2032
ITALY
  • Table 38: Italy Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • Table 39: Italy Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 40: Italy 13-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2020, 2026 & 2032
UNITED KINGDOM
  • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
  • Table 41: UK Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • Table 42: UK Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 43: UK 13-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2020, 2026 & 2032
SPAIN
  • Table 44: Spain Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • Table 45: Spain Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 46: Spain 13-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2020, 2026 & 2032
RUSSIA
  • Table 47: Russia Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • Table 48: Russia Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 49: Russia 13-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2020, 2026 & 2032
REST OF EUROPE
  • Table 50: Rest of Europe Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • Table 51: Rest of Europe Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 52: Rest of Europe 13-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2020, 2026 & 2032
AUSTRALIA
  • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
INDIA
  • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
SOUTH KOREA
REST OF ASIA-PACIFIC
LATIN AMERICA
  • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
  • Table 53: Latin America Recent Past, Current & Future Analysis for Apigenin by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • Table 54: Latin America Historic Review for Apigenin by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 55: Latin America 13-Year Perspective for Apigenin by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2020, 2026 & 2032
  • Table 56: Latin America Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • Table 57: Latin America Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 58: Latin America 13-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2020, 2026 & 2032
ARGENTINA
  • Table 59: Argentina Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • Table 60: Argentina Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 61: Argentina 13-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2020, 2026 & 2032
BRAZIL
  • Table 62: Brazil Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • Table 63: Brazil Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 64: Brazil 13-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2020, 2026 & 2032
MEXICO
  • Table 65: Mexico Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • Table 66: Mexico Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 67: Mexico 13-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2020, 2026 & 2032
REST OF LATIN AMERICA
  • Table 68: Rest of Latin America Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • Table 69: Rest of Latin America Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 70: Rest of Latin America 13-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2020, 2026 & 2032
MIDDLE EAST
  • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
  • Table 71: Middle East Recent Past, Current & Future Analysis for Apigenin by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • Table 72: Middle East Historic Review for Apigenin by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 73: Middle East 13-Year Perspective for Apigenin by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2020, 2026 & 2032
  • Table 74: Middle East Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • Table 75: Middle East Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 76: Middle East 13-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2020, 2026 & 2032
IRAN
  • Table 77: Iran Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • Table 78: Iran Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 79: Iran 13-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2020, 2026 & 2032
ISRAEL
  • Table 80: Israel Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • Table 81: Israel Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 82: Israel 13-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2020, 2026 & 2032
SAUDI ARABIA
  • Table 83: Saudi Arabia Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • Table 84: Saudi Arabia Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 85: Saudi Arabia 13-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2020, 2026 & 2032
UNITED ARAB EMIRATES
  • Table 86: UAE Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • Table 87: UAE Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 88: UAE 13-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2020, 2026 & 2032
REST OF MIDDLE EAST
  • Table 89: Rest of Middle East Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • Table 90: Rest of Middle East Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 91: Rest of Middle East 13-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2020, 2026 & 2032
AFRICA
  • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
  • Table 92: Africa Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • Table 93: Africa Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 94: Africa 13-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2020, 2026 & 2032
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Anhui Sinotech Industrial
  • Cayman Chemical Company
  • Chengdu Chenlv Biological Technology
  • Codeage LLC
  • Enzo Life Sciences, Inc.
  • Fuyang Bestop Import And Export Ltd.
  • Glentham Life Sciences Ltd.
  • HealthTech BioActives
  • Hello Bio Ltd.
  • INDOFINE Chemical Company, Inc.
  • Jinan Tantu Chemicals
  • Lanyor Biotech Co., Ltd.
  • Mianyang Di`ao Pharmaceutical Co., Ltd.
  • S. Nihar Exports
  • Selleck Chemicals
  • Shaanxi Pioneer Biotech Co., Ltd.
  • Sunriver Biotech
  • Wuhan Hengheda Pharm Co., Ltd.
  • Xi`an Arisun ChemPharm Co., Ltd.
  • Xi`an Bettering Biotech Co., Ltd.

Table Information